Innovative MedTech Inc. (IMTH)
USD 0.58
(0.0%)
USD 0.58
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 6.09 Million USD | 14.02% |
| 2023 | 5.34 Million USD | -72.65% |
| 2022 | 19.55 Million USD | 1748.33% |
| 2021 | 1.05 Million USD | 179.62% |
| 2020 | 378.37 Thousand USD | 79.28% |
| 2019 | 211.05 Thousand USD | 0.0% |
| 2014 | 335.96 Thousand USD | 18.18% |
| 2013 | 284.27 Thousand USD | -79.98% |
| 2012 | 1.42 Million USD | 33.23% |
| 2011 | 1.06 Million USD | -19.79% |
| 2010 | 1.32 Million USD | 121.49% |
| 2009 | 599.94 Thousand USD | -58.0% |
| 2008 | 1.42 Million USD | 30.86% |
| 2007 | 1.09 Million USD | 58.82% |
| 2006 | 687.37 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 3.52 Million USD | 161.59% |
| 2024 Q3 | 1.34 Million USD | 130.72% |
| 2024 Q2 | 581.64 Thousand USD | -7.31% |
| 2024 Q1 | 627.51 Thousand USD | -49.8% |
| 2023 Q2 | 1.35 Million USD | 0.42% |
| 2023 Q1 | 1.34 Million USD | -92.51% |
| 2023 FY | 5.34 Million USD | -72.65% |
| 2023 Q4 | 1.24 Million USD | -10.67% |
| 2023 Q3 | 1.39 Million USD | 3.43% |
| 2022 FY | 19.55 Million USD | 1748.33% |
| 2022 Q4 | 17.97 Million USD | 3599.56% |
| 2022 Q3 | 485.96 Thousand USD | 1.97% |
| 2022 Q2 | 476.57 Thousand USD | -22.47% |
| 2022 Q1 | 614.72 Thousand USD | 30.62% |
| 2021 Q1 | 33.27 Thousand USD | 0.0% |
| 2021 Q4 | 470.6 Thousand USD | -1.44% |
| 2021 Q2 | 76.65 Thousand USD | 130.4% |
| 2021 Q3 | 477.49 Thousand USD | 522.92% |
| 2021 FY | 1.05 Million USD | 179.62% |
| 2020 FY | 378.37 Thousand USD | 79.28% |
| 2019 FY | 211.05 Thousand USD | 0.0% |
| 2015 Q1 | 110.62 Thousand USD | 88.63% |
| 2014 Q1 | 58.78 Thousand USD | 0.0% |
| 2014 Q4 | 58.65 Thousand USD | 1.28% |
| 2014 Q3 | 57.9 Thousand USD | -46.77% |
| 2014 FY | 335.96 Thousand USD | 18.18% |
| 2014 Q2 | 108.78 Thousand USD | 85.06% |
| 2013 FY | 284.27 Thousand USD | -79.98% |
| 2013 Q4 | 58.78 Thousand USD | 0.86% |
| 2013 Q1 | 633.83 Thousand USD | 388.81% |
| 2013 Q2 | 108.43 Thousand USD | -82.89% |
| 2013 Q3 | 58.28 Thousand USD | -46.25% |
| 2012 Q2 | 295.31 Thousand USD | 105.91% |
| 2012 FY | 1.42 Million USD | 33.23% |
| 2012 Q4 | 129.66 Thousand USD | -63.99% |
| 2012 Q3 | 360.06 Thousand USD | 21.92% |
| 2012 Q1 | 143.41 Thousand USD | -20.99% |
| 2011 Q1 | 569.45 Thousand USD | 47.59% |
| 2011 FY | 1.06 Million USD | -19.79% |
| 2011 Q4 | 181.52 Thousand USD | -55.69% |
| 2011 Q3 | 409.7 Thousand USD | 23.68% |
| 2011 Q2 | 331.25 Thousand USD | -41.83% |
| 2010 FY | 1.32 Million USD | 121.49% |
| 2010 Q1 | 9893.00 USD | -92.51% |
| 2010 Q2 | 154.07 Thousand USD | 1457.38% |
| 2010 Q3 | 203.21 Thousand USD | 31.9% |
| 2010 Q4 | 385.83 Thousand USD | 89.86% |
| 2009 Q1 | 284.63 Thousand USD | -34.16% |
| 2009 Q4 | 132.07 Thousand USD | -58.27% |
| 2009 Q3 | 316.48 Thousand USD | 94.55% |
| 2009 Q2 | 162.67 Thousand USD | -42.85% |
| 2009 FY | 599.94 Thousand USD | -58.0% |
| 2008 Q2 | 474.43 Thousand USD | 35.09% |
| 2008 Q1 | 351.2 Thousand USD | -5.82% |
| 2008 Q3 | 237.23 Thousand USD | -50.0% |
| 2008 Q4 | 432.3 Thousand USD | 82.23% |
| 2008 FY | 1.42 Million USD | 30.86% |
| 2007 Q3 | 158.84 Thousand USD | -23.92% |
| 2007 Q4 | 372.89 Thousand USD | 134.76% |
| 2007 FY | 1.09 Million USD | 58.82% |
| 2007 Q1 | 133.83 Thousand USD | 21.65% |
| 2007 Q2 | 208.77 Thousand USD | 56.0% |
| 2006 Q3 | 344.46 Thousand USD | -35.09% |
| 2006 Q2 | 530.66 Thousand USD | 0.0% |
| 2006 Q4 | 110.01 Thousand USD | -68.06% |
| 2006 FY | 687.37 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -113.004% |
| Ansell Limited | 495.5 Million USD | 98.769% |
| Ansell Limited | 495.5 Million USD | 98.769% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 92.634% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -252.389% |
| Psykey, Inc. | 1.21 Million USD | -402.604% |
| ConvaTec Group Plc | 910.31 Million USD | 99.33% |
| ConvaTec Group Plc | 872.5 Million USD | 99.301% |
| Encision Inc. | 3.77 Million USD | -61.488% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -4200.795% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -5448.026% |
| LifePoint, Inc. | 7.42 Million USD | 17.846% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 3.938% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -613.333% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -739.928% |
| Reflect Scientific, Inc. | 1.06 Million USD | -473.377% |
| SmileDirectClub, Inc. | 517 Million USD | 98.82% |
| Sector 10, Inc. | 39.84 Thousand USD | -15207.201% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.908% |
| SheerVision, Inc. | 2.33 Million USD | -161.576% |
| United Health Products, Inc. | 2.42 Million USD | -151.346% |
| Vasamed, Inc. | 4.67 Million USD | -30.518% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -138.074% |
| Yubo International Biotech Limited | 1.25 Million USD | -384.865% |